NICOLE RAWLE: Open Payments
NPI 1669777314 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 17 payments from 12 companies in 2025. Trend: 2023 $930 · 2024 $946 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| ABBVIE INC. | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| GENZYME CORPORATION | 1 | $30 |
| LEO Pharma Inc. | 1 | $28 |
| UCB, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
Products named: COSENTYX, SKYRIZI, ILUMYA, LITFULO, DUPIXENT, ADBRY, Bimzelx, TREMFYA.
Industry payments across UT — which companies pay providers there.
